The makers of an expensive cholesterol-lowering drug plan to offer discounts of up to 69% in exchange for insurers and pharmacy-benefit managers expanding their coverage of the medicine to more patients.
from WSJ.com: US Business http://ift.tt/2Fxi66a
via IFTTT
No comments:
Post a Comment